Log In
BCIQ
Print this Print this
 

Gelvac

  Manage Alerts
Collapse Summary General Information
Company Nanotherapeutics Inc.
DescriptionNasal powder H5N1 (bird flu) influenza vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$0.1M

$0.1M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/12/2009

$0.1M

$0.1M

0

Get a free BioCentury trial today